文献速递胃肠外科围术期管理与 ERAS

机器人辅助与腹腔镜直肠癌侧方淋巴结清扫的Meta分析:疗效与安全性比较

Meta-analysis of the efficacy and safety of robot-assisted comparative laparoscopic surgery in lateral lymph node dissection for rectal cancer.
PubMed 文献 · Surg Endosc · 2024-08-01

该Meta分析纳入6项研究共652例直肠癌患者,比较机器人辅助(RLLND,316例)与腹腔镜(LLLND,336例)侧方淋巴结清扫的围手术期和肿瘤学结局。结果显示机器人组术中出血更少、住院时间更短、泌尿并发症和总体术后并发症发生率更低、侧方淋巴结清扫数目更多,但手术时间更长;吻合口漏、肠梗阻和淋巴结总数无显著差异。

要点

  • 机器人组术中出血量更少(MD=-22,95%CI -40.03至-3.97,P<0.05)。
  • 机器人组泌尿并发症(OR 0.39,95%CI 0.23至0.64)和总体术后并发症(OR 0.6,95%CI 0.42至0.87)更低。
  • 机器人组侧方淋巴结清扫数目更多(MD=1.18,95%CI 0.14至2.23),但手术时间更长(MD=51.57,95%CI 7.69至95.45)。

核心结论

  • 与腹腔镜相比,机器人辅助直肠癌侧方淋巴结清扫可减少术中出血、缩短住院时间、降低泌尿并发症和总体术后并发症、增加侧方淋巴结清扫数目,但延长手术时间。

研究设计与样本

  • Meta分析,检索PubMed、EMBASE、Cochrane和Web of Science从建库至2024年3月,纳入6项符合标准的前瞻性和回顾性研究,共652例患者(RLLND组316例,48.5%;LLLND组336例,51.5%),文献质量用NOS评分评估,使用R语言进行Meta分析,采用I2统计量评估异质性并进行敏感性分析。

主要发现

  • 机器人组与腹腔镜组相比,术中出血量MD=-22(95%CI -40.03至-3.97,P<0.05),手术时间MD=51.57(95%CI 7.69至95.45,P<0.05),住院时间MD=-1.25(95%CI -2.46至-0.05,P<0.05)。
  • 机器人组泌尿并发症OR=0.39(95%CI 0.23至0.64,P<0.01),总体术后并发症OR=0.6(95%CI 0.42至0.87,P<0.01),侧方淋巴结清扫数目MD=1.18(95%CI 0.14至2.23,P<0.05)。
  • 两组术后吻合口漏、术后肠梗阻和淋巴结总数差异无统计学意义(P>0.05)。

临床怎么用

  • 对于直肠癌侧方淋巴结清扫,机器人辅助手术在减少出血、降低泌尿并发症和总体并发症、增加侧方淋巴结清扫数目方面可能优于腹腔镜,但需权衡更长的手术时间。

局限性

  • 纳入研究数量少(仅6项),且包含回顾性研究,可能存在选择偏倚和异质性,结论可靠性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A meta-analysis was conducted on the perioperative and oncological outcomes of robot-assisted and laparoscopic lateral lymph node dissection in rectal cancer. There are few articles and reports on this topic, and a lack of high-quality research results in unreliable research conclusions. This study includes prospective and retrospective studies to obtain more reliable findings. MATERIALS AND METHODS: Databases were searched, including PubMed, EMBASE, Cochrane, and Web of Science. The search was conducted from the time of database construction to March 2024. The quality of the literature was evaluated using the NOS scoring system. Meta-analysis was performed using R language software. Statistical heterogeneity was assessed using the I2 statistic, and sensitivity analysis was performed. RESULTS: Six relevant literatures that met the criteria were finally included, and 652 patients were included, including 316 (48.5%) in the robot-assisted lateral lymph node dissection for rectal cancer group (RLLND) and 336 (51.5%) in the laparoscopic lateral lymph node dissection for rectal cancer group (LLLND). Analysis of the results showed that compared with the laparoscopic group, the robotic group had less mean intraoperative blood loss (MD = - 22, 95% CI - 40.03 to - 3.97, P < 0.05), longer operative time (MD = 51.57, 95%CI 7.69 to 95.45, P < 0.05), and a shorter mean hospital stay (MD = - 1.25, 95%CI - 2.46 to - 0.05, P < 0.05), a low rate of urinary complications (OR 0.39, 95%CI 0.23 to 0.64, P < 0.01), a low overall rate of postoperative complications (OR 0.6, 95%CI 0.42 to 0.87, P < 0.01), and a high number of lateral lymph node dissection (MD = 1.18, 95% CI 0.14 to 2.23, P < 0.05), and there was no statistically significant difference between the two groups in terms of postoperative anastomotic leakage, postoperative intestinal obstruction, and total number of lymph nodes obtained (P > 0.05). CONCLUSION: Compared with laparoscopy, robotic lateral lymph node dissection for rectal cancer reduces intraoperative blood loss, shortens the average length of hospital stay, reduces urologic complications, decreases overall postoperative complications, and collects more lateral lymph nodes. However, the surgical time is prolonged.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Shi H, Yi X, Yan X, et al. Meta-analysis of the efficacy and safety of robot-assisted comparative laparoscopic surgery in lateral lymph node dissection for rectal cancer. Surg Endosc. 2024. PMID: 39090200. doi:10.1007/s00464-024-11111-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。